Li, Terry http://orcid.org/0000-0001-5629-4763
Click, Benjamin
Bachour, Salam
Sachs, Michael
Barnes, Edward L.
Cohen, Benjamin L.
Contreras, Susell
Axelrad, Jordan
Funding for this research was provided by:
Crohn's and Colitis Foundation of America
National Institute of Health (K23DK124570, K23DK127157)
Judith & Stewart Colton Center for Autoimmunity
Article History
Received: 17 March 2023
Accepted: 13 July 2023
First Online: 7 August 2023
Declarations
:
: Jordan E. Axelrad reports research grants from BioFire Diagnostics; consultancy fees, honorarium, or advisory board fees from BioFire Diagnostics, Janssen, Pfizer, Bristol Myers Squibb, Adiso, and Abbvie. Terry Li reports no disclosures. Salam P. Bachour reports no disclosures. Michael C. Sachs reports no disclosures. Edward L. Barnes reports consulting for AbbVie, Gilead, Pfizer, and TARGET-RWE. Benjamin L. Cohen receives financial support for advisory boards and consultant for Abbvie, Celgene-Bristol Myers Squibb, Pfizer, Sublimity Therapeutics, Takeda, and TARGET-RWE; CME Companies: Cornerstones and Vindico; and Speaking: Abbvie. Benjamin Click reports consulting fees for IBD Education Group, TARGET-RWE, and Takeda. Susell Contreras reports no disclosures.
: The institutional review board approved this study at participating centers. All ethical principles laid out in the Declaration of Helsinki were followed.